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INTRODUCTION
Fulminant hepatic failure carries a very high mortality of
80-90% (1). Orthotopic liver transplantation has now become
the treatment of choice of fulminant hepatic failure, with a
survival rate of 50-75% after 1 yr (2). But, spontaneous sur-
vival rate of patients with fulminant hepatic failure ranges
from 15% to 25% (3). Therefore, a liver assist device to help
the liver recover spontaneously can be an alternative method to
replace orthotopic liver transplantation or a bridge to patients
waiting for a suitable donor in preventing the occurrence of
irreversible neurologic damage. Several devices have been
developed and employed clinically. 
To prove the functional support of liver assist devices in ful-
minant hepatic failure, it is necessary to establish a standard-
ized hepatic failure model which closely correlates with clini-
cal situations and can be reproduced in large animals. There
are several animal models of hepatic failure. The surgical mod-
els include total hepatectomy, partial or complete devascu-
larization, and portacaval shunt with 70% partial hepatec-
tomy (4-7). The pharmacological models include D-galac-
tosamine, acetaminophen, and carbon tetrachloride (4, 8-12).
The aim of these models is to simulate acute fulminant hepat-
ic failure that results in the rapid onset of hepatic coma and
death. Even though the application of liver assist devices in
human has been performed, the additional development of
technology and demonstration of safety, efficacy, and mech-
anism of action should be greatly accelerated by testing a clini-
cally relevant large animal model. 
Ischemic injury is one of the reasons for hepatic failure (6).
For pigs, the tolerable period of hepatic ischemia varies from
35 to 180 min (6, 14-16). If the time of hepatic ischemia
exceeds the tolerable period, hepatocytes can be injured irre-
versibly and necrosis can occur, too. In the present study, we
have evaluated a model of fulminant hepatic failure induced
by clamping the portal vein and the hepatic artery intermit-
tently to cause reperfusion injury to the liver and then by lig-
ating hepatic artery at the end of the last clamping.
MATERIALS AND METHODS
Animals 
Female white pigs, weighing from 17 kg to 25 kg, were
used for this experiment. One day before surgery, 20 g mag-
nesium sulfate was administered orally for bowel cleansing
and then pigs were fasted. All the experiments were conducted
under the supervision of a veterinarian according to local insti-
tutional guidelines for the care and use of laboratory animals.
Operative procedure
All operative procedures were performed at the “Clinical
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An Experimental Animal Model of Fulminant Hepatic Failure in Pigs
The objective of this study was to develop an experimental animal model of fulmi-
nant hepatic failure to test the efficacy of the bioartificial liver system. The portal
vein and the hepatic artery were clamped intermittently and then the hepatic artery
was ligated (ligation group, n=5). Pigs whose hepatic arteries were not ligated after
clamping were assigned to the non-ligation group (n=5). The biochemical changes
in blood, histologic alterations of the liver and neurologic examination for pigs were
checked up. All animals died within 17 hr in the ligation group. On the other hand,
all animals survived more than 7 days in the non-ligation group. In the ligation group,
the levels of ammonia, lactic acid and creatinine showed a progressively increas-
ing pattern. Prothrombin time was also prolonged gradually. Cytoplasmic conden-
sation and nuclear pyknosis of hepatocytes were detected histologically at autop-
sy. Neurologic findings such as decreased pain sensation, tachypnea and no light
reflex of pupils were observed. The findings shown in the ligation group are similar
to the clinical features of fulminant hepatic failure in human and this animal model
is reproducible. Therefore, this can be a suitable animal model to evaluate the effi-
cacy of the bioartificial liver system for treating fulminant hepatic failure.
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Research Institute, Seoul National University Hospital. Pre-
medication was performed with an intramuscular injection
of ketamine chloride (25 mg/kg). After injecting Pentothal
sodium (2 mg/kg), the animals were intubated and ventilat-
ed with a mixture of nitrous oxide, oxygen, and enflurane.
One catheter was placed in the external jugular vein for infu-
sion and another catheter was introduced into the femoral
artery for both blood pressure monitoring and blood sam-
pling. The abdomen was opened by a midline incision. The
common bile duct, the hepatic artery, and the portal vein were
exposed. A sling was laid around the hepatic artery and the
portal vein for clamping. It took 25 min for the 1st and 2nd
clamping and 30 min for the 3rd and 4th. The hepatic artery
was ligated after the 4th clamping (ligation group, n=5).
Pigs whose hepatic artery was not ligated after clamping
were assigned to the non-ligation group (n=5). The inter-
vals between each clamping were 30 min and total clamp-
ing time was 110 min.
During the operation, lactated Ringer’s solution was given
and 8.4% NaHCO3 and calcium gluconate were administered
for the maintenance of physiologic status. Five furosemide
injections (10 mg) were totally given every 90 min to make
them excrete potassium. The anesthesia was discontinued after
the operation was over. The animals were kept in isolated cages
and carefully controlled and their behaviors were registered. 
Clinical assessment 
The behaviors of the animals after awaking from anesthe-
sia were controlled continuously. The following criteria were
registered: abilities to get up, to walk, and to respond to pain-
ful stimuli, and also light reflex of pupils. The purpose of
these observations was to detect the signs of hepatic encepha-
lopathy. 
Biochemical measurements 
Blood sampling was done four times: before clamping, after
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Fig. 1. Evolution of ammonia and lactic acid (mean±SD) before clamping, after 4 hr and 7 hr since the first clamping, and before death (in non-
ligation group, 20 hr after clamping).
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Fig. 2. Evolution of total bilirubin, AST, and ALT (mean±SD) before clamping, after 4 hr and 7 hr since the first clamping, and before death
(in non-ligation group, 20 hr after clamping).
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4 hr and 7 hr since the first clamping respectively, and lastly
before death (in non-ligation group, 20 hr after clamping).
And the following parameters were measured from the experi-
ment: glucose, aspartate transaminase (AST), alanine transami-
nase (ALT), total bilirubin, blood urea nitrogen (BUN), cre-
atinine, ammonia, potassium, lactic acid, prothrombin time
(PT) and pH. The PT was not checked in the time when it
has passed 7 hr since the first clamping. 
Histologic evaluations 
Specimens of the liver were taken three times: before clamp-
ing, after 4 hr since the first clamping, and immediately after
death (in non-ligation group, 20 hr after clamping). By means
of liver biopsy, liver tissues were fixed by 1 cm thickness in
10% formalin. After fixation, 27 m sections of each biopsy
were stained with hematoxylin eosin and examined by light
microscopy.
Statistical analysis 
Data were expressed as mean values±standard deviation
(SD). Biochemical data were compared to the baseline level
by use of Wilcoxon signed rank test. The level of statistical
significance was set at p<0.05.
RESULTS
Survival
In the ligation group, the first animal died from hyperkale-
mia at 6.5 hr after ligation of the hepatic artery. The reason was
that 8.4% NaHCO3and calcium gluconate were not adminis-
tered. The remaining 4 animals were administered and died
after the duration of 14.4±2.1 hr (range: 12.5-17.0). In the
non-ligation group, all five animals have survived for more
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Fig. 4. Evolution of glucose and PT (mean±SD) before clamping, after 4 hr and 7 hr since the first clamping, and before death (in non-
ligation group, 20 hr after clamping). The PT was not checked in the third measure after the clamping, that is, in the time when it has
passed 7 hr since the first clamping.
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Fig. 3. Evolution of BUN, creatinine, and potassium (mean±SD) before clamping, after 4 hr and 7 hr since the first clamping, and before
death (in non-ligation group, 20 hr after clamping).
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Clinical assessment
The animals in the non-ligation group did not show marked
behavioral abnormalities. The first abnormality observed in
the ligation group was usually ataxic gait and impaired bal-
ance. And then drowsiness, a decrease in pain sensations, and
the posture like walking in the air spontaneously at supine
position were followed in 10 hr after ligating the hepatic artery.
The loss of sensation, absence of light reflex, and nonreactive
coma developed after 10 hr since ligating the hepatic artery. 
Biochemical assessment
Metabolic acidosis was observed after intermittent clamp-
ing of the portal vein and the hepatic artery, but it was cor-
rected by administration of sodium bicarbonate. In the non-
ligation group, the levels of ammonia, lactic acid, AST, ALT,
and creatinine gradually declined after showing increased val-
ues initially, whereas BUN and potassium remained within
the normal range. In the ligation group, the levels of ammo-
nia, lactic acid, and creatinine showed a progressively increas-
ing pattern. The levels of ammonia, lactic acid, total biliru-
bin, and BUN increased after 4 hr of hepatic ligation. How-
ever, the difference were not significant statistically. The in-
crease of AST, ALT, creatinine, and potassium was not sig-
nificant statistically, either. PT recovered normal range after
slight prolongation in the non-ligation group, but it was gra-
dually prolonged in the ligation group (Fig. 1-4).  
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Fig. 5. (A) Hematoxylin-eosin-stained specimen before clamping
the portal triad in pigs (×100). Image shows normal portal tract
in the pig liver. (B) Specimen after 4 hr since the first clamping in
the non-ligation group (×100). Widened portal spaces with infil-
tration of a few inflammatory cells and ischemic changes of hepa-
tocytes in porto-to portal space are shown but there are no necrot-
ic hepatocytes. The sinusoidal spaces are dilated. (C) Specimen
after 20 hr since the first clamping in the non-ligation group (×100).
There are no histologic differences from those of (B).
A B
C
Fig. 6. Hematoxylin-eosin-stained specimen after 4 hr since ligat-
ing the hepatic artery in pigs (×100). The findings are similar to
those of the non-ligation group but, cytoplasmic condensation and
unclear pyknosis in focal areas are found.Histopathology 
The histologic features in the non-ligation group which
were checked before clamping, after 4 hr and 20 hr since the
first clamping, respectively were shown in Fig. 5. There were
no histologic differences: widened portal spaces with infiltra-
tion of a few inflammatory cells, ischemic changes of the hepa-
tocytes in porto-to-portal space, and dilated sinusoidal spaces.
The findings obtained after 4 hr since ligating the hepatic
artery (Fig. 6) were similar to those of the non-ligation group
but nuclear pyknosis and cytoplasmic condensation were found
in focal area. At autopsy, the histologic features mentioned
above were also shown and furthermore parenchymal hem-
orrhage, necrosis, nuclear pyknosis and cytoplasmic conden-
sation in a multifocal area were shown (Fig. 7).
DISCUSSION
In the orthotopic liver transplantation, transient ischemia
and reperfusion injury is one of the reasons of graft failure
(13). Nitta et al. (16) reported that impairment of hepatic
energy metabolism by intermittent portal triad cross-clamp-
ing is mainly due to reinflow of pooled-portal blood to the
previously ischemic liver rather than hepatic warm ischemia.
Li et al. (17) demonstrated that in the simple model of ortho-
topic hepatic autotransplantation in case of dogs, the exten-
sion of hepatic arterial ischemic time showed obvious ultra-
microstructural changes in the liver and biliary duct, and the
levels of serum bilirubin and ALT were elevated. The ischemia
and reperfusion injury was represented in this model and
splanchnic venous congestion was resolved by declamping
the portal triad. Although several investigators verified that
ischemia and reperfusion injury was the main cause of hep-
atic failure in the experimental animal studies, additional
hepatic artery ligation was needed to develop hepatic failure
in our model. 
Terblanche et al. (4) suggested that five criteria should be
met for a good animal model of hepatic failure: 1) reprodu-
cibility, 2) potential reversibility, 3) the agent used to pro-
duce liver failure should cause selective liver damage, 4) use
of a large animal, and 5) the lack of relevant biohazard. In the
present study, the surgical experimental model of liver fail-
ure was reproducible. It has supported original anatomy of
the portal vein and bile duct systems. Therefore liver regen-
eration can be possible if a liver assist device is applied. Hep-
atic coma was induced by massive hepatocytes necrosis and
death could be attributed to progressive liver failure. The mor-
tality rate was 100% when the hepatic artery was ligated after
the intermittent clamping and the declamping of the portal
triad. The period before death was long enough to allow the
use of liver assist devices. Therefore, all requirements for ideal
hepatic failure model except reversibility are fulfilled in this
study.
In our model, the plasma level of ammonia increased, al-
though it was not significant statistically. Ammonia is a neu-
rotoxin which may precipitate hepatic encephalopathy. In the
brain, ammonia may induce changes of blood-to-brain trans-
portation of amino acids and alterations of brain energy meta-
bolism. Furthermore, ammonia directly alters neuronal electric
activity by inhibiting the generation of both excitatory and
inhibitory post-synaptic potentials (18). Hyperammonemia is
typical of fulminant hepatic failure and it indicates an impaired
detoxification system.
In the ligation group, the levels of total bilirubin, AST and
ALT increased progressively. Lactic acid increased abruptly
and then progressively. It suggested a failure of hepatic clear-
ance of peripherally generated lactic acid in the shock state
(8). PT was gradually prolonged in the ligation group. Coagu-
lopathy occurred as a result of decreased synthesis of clotting
factors and disseminated intravascular coagulation (19). The
transient increase in the level of blood glucose after clamp-
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Fig. 7. Hematoxylin-eosin-stained specimens at autopsy in the ligation group (×400). The histologic features mentioned at Fig. 5B and
Fig. 6 are also shown. In addition parenchymal hemorrhage, necrosis, nuclear pyknosis and cytoplasmic condensation in multifocal
areas are shown.
A Bing the portal vein and the hepatic artery in two groups was
considered as a stress reaction. And it was believed for the
increase to be caused by the mobilization of glycogen stores.
Hypoglycemia which is a characteristic of fulminant hepat-
ic failure was seen in the ligation group. It has been shown
from the result of inhibiting both gluconeogenesis and glu-
cose release from the liver into the blood stream and failure
of insulin metabolism (11). But hypoglycemia is not a major
factor to bring on coma or death.
This model also showed features of hepatic encephalopa-
thy by inducing massive necrosis of hepatocytes and releas-
ing the toxic by-products into systemic circulation through
the portal vessel and bile duct systems. In the ligation group,
except for the first animal, the other four pigs showed the
posture like spontaneously walking in the air at supine posi-
tion. The animals lost pain sensation for some hours before
death and even pupils did not respond to light for some hours
before death. This neurological changes are similar to those
of fulminant hepatic failure model in pigs induced by D-
galactosamine or graded devascularization (5, 9).
In conclusion, our new model is similar to the hepatic fail-
ure in human beings according to the clinical, laboratory and
pathologic findings. It may be the advantage of this model
that we can make it technically easily, which makes it highly
reproducible. To develop fulminant hepatic failure, it is nec-
essary not only to induce the ischemia and reperfusion injury
to the liver parenchyma by intermittent clamping and declam-
ping the portal triad, but also to ligate the hepatic artery. This
model can be used to test the efficacy of liver assist devices.
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